Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Forbes

Why Pharma Boards Confuse Scenario Models With Risk Measurements

Why Pharma Boards Confuse Scenario Models With Risk Measurements
ShareXFacebook

You cannot see that decision when the base case and scenario are mashed into one frightening total. The board needs cleaner numbers.

F

Source

Forbes

Read full article at Forbes

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement